| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NTRA over the last quarter tilts toward selling: insiders offloaded a net 267,638 shares worth roughly $62.2M. In the past 30 days, 0 insiders bought and 8 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 8 insiders sold in the same window, though all of them still hold shares. Classified under Life Sciences Tools & Services (Health Care sector), NTRA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.28M | $732.90M | -2,449 | |
| Dir | 245.6K | $79.11M | -5,238 | |
| Pres | 183.8K | $59.19M | -2,008 | |
| Other | 170.1K | $54.78M | -2,221 | |
| Pres | 130.4K | $42.00M | -5,624 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $130.78 | $745,470.73 | -0.5% | +30.6% | +48.8% | |
| Oct 31, 2024 | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,866 | $126.45 | $235,955.70 | -2.6% | +39.1% | +64.5% | |
| Oct 29, 2024 | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,992 | $118.86 | $236,771.82 | -1.4% | +32.5% | +54.6% | |
| Oct 28, 2024 | Rabinowitz Daniel47 | Sec. And Chief Legal Officer | Sell | 1,057 | $118.21 | $124,948.50 | -0.5% | +36.9% | +57.0% | |
| Oct 28, 2024 | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,196 | $118.21 | $141,379.76 | -1.1% | +36.9% | +57.0% | |
| Oct 28, 2024 | Chapman Steven Leonard56 | CEO And President | Sell | 3,960 | $118.21 | $468,113.58 | -2.0% | +36.9% | +57.0% | |
| Oct 28, 2024 | Fesko John | President, Chief Bus. Officer | Sell | 929 | $118.21 | $109,817.55 | -0.8% | +36.9% | +57.0% | |
| Oct 25, 2024 | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,605 | $119.03 | $191,037.37 | -1.1% | +46.0% | +63.6% | |
| Oct 23, 2024 | Brophy Michael Burkes47 | Chief Financial Officer | Sale+OE | 496 | $119.09 | $59,068.49 | -0.7% | +41.1% | +64.3% | |
| Oct 22, 2024 | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 256 | $120.07 | $30,737.92 | -0.2% | +39.6% | +56.7% |